Shurin, Michael R.
Immune-Mediated Diseases
1. Immune-Mediated Diseases: Where Do We Stand?
Michael R. Shurin, Yuri S. Smolkin
2. The Four Most Common Pediatric Immunodeficiencies
Richard E. Stiehm
3. Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Inheritance: Model for Autoaggression
Hans D. Ochs, Troy R. Torgerson
4. DiGeorge Syndrome/Velocardiofacial Syndrome: The Chromosome 22q11.2 Deletion Syndrome
Kathleen E. Sullivan
5. Leukocyte Adhesion Deficiencies: Molecular Basis, Clinical Findings, and Therapeutic Options
Amos Etzioni
6. Nijmegen Breakage Syndrome
Irina Kondratenko, Olga Paschenko, Alexandr Polyakov, Andrey Bologov
7. Neutrophil Activity in Chronic Granulomatous Disease
Vladimir Pak, Anna Budikhina, Mikhail Pashenkov, Boris Pinegin
8. Mycobacterial Infections in Primary Immunodeficiency Patients
Elizaveta Galkina, Irina Kondratenko, Andrey Bologov
9. SLE 1, 2, 3...Genetic Dissection of Lupus
Jiankun Zhu, Chandra Mohan
10. Network of Myeloid and Plasmacytoid Dendritic Cells in Atopic Dermatitis
Natalija Novak, Wenming Peng, Chunfeng Yu
11. Peptide-Based Therapy in Lupus: Promising Data
Fanny Monneaux, Sylviane Muller
12. Reduced Number and Function of CD4
Elena Yu. Lyssuk, Anna V. Torgashina, Sergey K. Soloviev, Evgeny L. Nassonov, Svetlana N. Bykovskaia
13. Role of Altered Expression of HLA Class I Molecules in Cancer Progression
Natalia Aptsiauri, Teresa Cabrera, Rosa Mendez, Angel Garcia-Lor, Francisco Ruiz-Cabello, Federico Garrido
14. Intrathymic Selection: New Insight into Tumor Immunology
Dmitry B. Kazansky
15. Crosstalk Between Apoptosis and Antioxidants in Melanoma Vasculogenic Mimicry
Amalia Vartanian, Anatoly Yu. Baryshnikov
16. Immunological Role of Dendritic Cells in Cervical Cancer
Alagar Manickam, Muthukumaran Sivanandham, Irina L. Tourkova
17. Sensitizing Tumor Cells to Immune-Mediated Cytotoxicity
Anil Shanker, Thomas Sayers
18. Inhibition of Dendritic Cell Generation and Function by Serum from Prostate Cancer Patients: Correlation with Serum-Free PSA
Maryam Aalamian-Matheis, Gurkamal S. Chatta, Michael R. Shurin, Edith Huland, Hartwig Huland, Galina V. Shurin
19. Alarmins Initiate Host Defense
Joost J. Oppenheim, Poonam Tewary, Gonzalo de la Rosa, De Yang
20. Gangliosides as Immunomodulators
Miroslava Potapenko, Galina V. Shurin, Joel de Leòn
21. Functional Changes of Macrophages Induced by Dimeric Glycosaminylmuramyl Pentapeptide
Anna Ilinskaya, Natalia Oliferuk, Valerii Livov, Rakhim M. Khaitov
22. Myeloid-Derived Suppressor Cells
Srinivas Nagaraj, Dmitry I. Gabrilovich
23. The Lytic NK Cell Immunological Synapse and Sequential Steps in Its Formation
Jordan S. Orange
24. Infective, Neoplastic, and Homeostatic Sequelae of the Loss of Perforin Function in Humans
Joseph A. Trapani, Ilia Voskoboinik
25. Natural Killer T (NKT) Cell Subsets in Chlamydial Infections
Xi Yang
26. Memory T Cells in Allograft Rejection
Anna Valujskikh
27. Differences in Dendritic Cell Activation and Distribution After Intravenous, Intraperitoneal, and Subcutaneous Injection of Lymphoma Cells in Mice
Alexandra L. Sevko, Nadzeya Barysik, Lori Perez, Michael R. Shurin, Valentin Gerein
28. Role of IL-1-Mediated Inflammation in Tumor Angiogenesis
Elena Voronov, Yaron Carmi, Ron N. Apte
29. New Approaches for Monitoring CTL Activity in Clinical Trials
Anatoli Malyguine, Susan Strobl, Liubov Zaritskaya, Michael Baseler, Kimberly Shafer-Weaver
30. Serum Levels of Soluble HLA and IL-2R Molecules in Patients with Urogenital Chlamydia Infection
Victor V. Novikov, Natalya I. Egorova, Georgii Yu. Kurnikov, Irina V. Evsegneeva, Anatoly Yu. Baryshnikov, Alexandr V. Karaulov
31. Evaluation of Suspected Immunodeficiency
Thomas A. Fleisher
32. Frequently Ill Children
Tatiana Markova, Denis Chuvirov
33. Evaluation of Bactericidal Activity of Human BiologicalFluids by Flow Cytofluorimetry
Anna Budikhina, Boris Pinegin
34. Rational Development of Antigen-Specific Therapies for Type 1 Diabetes
Georgia Fousteri, Damien Bresson, Matthias Von Herrath
35. Interleukin-7 Immunotherapy
Claude Sportés, Ronald E. Gress
36. Transmembrane Interactions as Immunotherapeutic Targets:Lessons from Viral Pathogenesis
Alexander B. Sigalov
37. Tumor Cell Vaccines
Patricia L. Thompson, Sophie Dessureault
38. T Cell Tolerance to Tumors and Cancer Immunotherapy
Kimberly Shafer-Weaver, Michael Anderson, Anatoli Malyguine, Arthur A. Hurwitz
39. Herpes Simplex Virus: Treatment with Antimicrobial Peptides
Leonid V. Kovalchuk, Ludmila V. Gankovskaya, Oksana A. Gankovskaya, Vyacheslav F. Lavrov
40. Vaccine Containing Natural TLR Ligands Protects from Salmonella typhimurium Infection in Mice and Acute Respiratory Infections in Children
Boris Semenov, Vitaly Zverev
41. Lymphocyte Subpopulations in Melanoma Patients Treated withDendritic Cell Vaccines
Zaira G. Kadagidze, Anna A. Borunova, Tatiana N. Zabotina
42. Cell Technologies in Immunotherapy of Cancer
Vladimir Moiseyenko, Evgeny Imyanitov, Anna Danilova, Alexey Danilov, Irina Baldueva
43. Therapeutic Potential of Cannabinoid-Based Drugs
Thomas W. Klein, Catherine A. Newton
44. Micro- and Nanoparticle-Based Vaccines for Hepatitis B
Dhruba J. Bharali, Shaker A. Mousa, Yasmin Thanavala
45. Mast Cells, T Cells, and Inhibition by Luteolin: Implications for the Pathogenesis and Treatment of Multiple Sclerosis
Theoharis C. Theoharides, Duraisamy Kempuraj, Betina P. Iliopoulou
DRM-restrictions
Printing: not available
Clipboard copying: not available
- Author(s)
- Shurin, Michael R.
- Smolkin, Yuri S.
- Publisher
- Springer
- Publication year
- 2007
- Language
- en
- Edition
- 1
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9780387720050